Paper · 40965337
Fucosylated N-Glycan Landscape of Triple-Negative Breast Cancer.
Scott DA and 8 others. Mol Cancer Res, 2025. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Fucosylated N-Glycan Landscape of Triple-Negative Breast Cancer. Papers, record 40965337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40965337
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triple Negative Breast Neoplasms | Major topic |
| Polysaccharides | Major topic |
| Fucose | Major topic |
| Humans | |
| Female | |
| Glycosylation | |
| Glycomics | |
| Prognosis | |
| Biomarkers, Tumor | |
| Middle Aged |
Source PubMed
Grants19
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| S10OD030212 | NIH Office of the Director (OD) | S10OD030212 | PubMed and NIH | NIH RePORTER | |
| 5P20GM130457 | National Institute of General Medical Sciences (NIGMS) | P20GM130457 | PubMed and NIH | NIH RePORTER | |
| R21 CA263464 | NCI NIH HHS | United States | R21CA263464 | PubMed and NIH | NIH RePORTER |
| R21AR08430 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | F32AR008430 | PubMed and NIH | NIH RePORTER | |
| F32 AR008430 | NIAMS NIH HHS | United States | F32AR008430 | PubMed and NIH | NIH RePORTER |
| R01 AG078702 | NIA NIH HHS | United States | R01AG078702 | PubMed and NIH | NIH RePORTER |
| S10 OD025126 | NIH HHS | United States | S10OD025126 | PubMed and NIH | NIH RePORTER |
| R21 CA286287 | NCI NIH HHS | United States | R21CA286287 | PubMed and NIH | NIH RePORTER |
| R01CA253460 | National Cancer Institute (NCI) | R01CA253460 | PubMed and NIH | NIH RePORTER | |
| R01 CA253460 | NCI NIH HHS | United States | R01CA253460 | PubMed and NIH | NIH RePORTER |
1 to 10 of 19
See all 19 grantsTrials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,869,882 | Spatial N-glycomics of the normal breast microenvironment reveals fucosylated and high-mannose N-glycan signatures related to BI-RADS density and ancestry. | Glycobiology | 2024 | https://conductscience.org/library/papers/38869882 | PubMed |
| 2 | 32,296,576 | Metabolic reprogramming in triple-negative breast cancer. | Cancer Biol Med | 2020 | https://conductscience.org/library/papers/32296576 | PubMed |
| 3 | 11,485,743 | The alpha(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. | Immunity | 2001 | https://conductscience.org/library/papers/11485743 | PubMed |
| 4 | 19,449,840 | IDAWG: Metabolic incorporation of stable isotope labels for quantitative glycomics of cultured cells. | J Proteome Res | 2009 | https://conductscience.org/library/papers/19449840 | PubMed |
| 5 | 26,289,314 | Glycosylation in cancer: mechanisms and clinical implications. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/26289314 | PubMed |
| 6 | 30,138,110 | Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey. | Clin Chem Lab Med | 2019 | https://conductscience.org/library/papers/30138110 | PubMed |
| 7 | 34,752,419 | Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis. | JCI Insight | 2021 | https://conductscience.org/library/papers/34752419 | PubMed |
| 8 | 36,765,690 | Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36765690 | PubMed |
| 9 | 31,314,995 | Glycosylation and its implications in breast cancer. | Expert Rev Proteomics | 2019 | https://conductscience.org/library/papers/31314995 | PubMed |
| 10 | 35,766,466 | Novel Combined Enzymatic Approach to Analyze Nonsialylated N-Linked Glycans through MALDI Imaging Mass Spectrometry. | J Proteome Res | 2022 | https://conductscience.org/library/papers/35766466 | PubMed |
1 to 10 of 65
See all 65 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40965337
GET https://conductscience.org/api/papers/v1/40965337/references?page=2